96 related articles for article (PubMed ID: 1993147)
1. Induction of lesions of dermatitis herpetiformis by autologous serum.
Cox NH; Friedmann PS
Br J Dermatol; 1991 Jan; 124(1):69-73. PubMed ID: 1993147
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Dermatitis Herpetiformis Successfully Treated with Tetracycline and Niacinamide.
Wang Y; Yang B; Zhou G; Zhang F
Acta Dermatovenerol Croat; 2018 Oct; 26(3):273-275. PubMed ID: 30390734
[TBL] [Abstract][Full Text] [Related]
3. Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterations.
Smith SB; Harrist TJ; Murphy GF; Halperin AJ; Newell JB; Fallon JT; Fine JD; Mihm MC
Arch Dermatol; 1984 Mar; 120(3):324-8. PubMed ID: 6367664
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis.
Smith AD; Streilein RD; Hall RP
Br J Dermatol; 2002 Dec; 147(6):1109-17. PubMed ID: 12452859
[TBL] [Abstract][Full Text] [Related]
5. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
Caproni M; Cardinali C; D'Agata A; Selvaggi W; Fabbri P
Int Arch Allergy Immunol; 2002 May; 128(1):67-72. PubMed ID: 12037403
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis.
Antiga E; Quaglino P; Pierini I; Volpi W; Lami G; Bianchi B; Del Bianco E; Renzi D; Baroni G; Novelli M; Ponti R; Papini M; Di Lollo S; Calabrò AS; Fabbri P; Caproni M
J Dermatol Sci; 2015 Jan; 77(1):54-62. PubMed ID: 25465638
[TBL] [Abstract][Full Text] [Related]
8. Dermatitis herpetiformis.
Yost JM; Hale CS; Meehan SA; McLellan BN
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526342
[TBL] [Abstract][Full Text] [Related]
9. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wieczfinska J; Pniewska E; Zebrowski M; Waszczykowska E; Wozniacka A; Eusebio M; Pietruczuk M; Pawliczak R
Mediators Inflamm; 2015; 2015():870428. PubMed ID: 27057091
[TBL] [Abstract][Full Text] [Related]
10. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha.
Hall RP; Takeuchi F; Benbenisty KM; Streilein RD
J Invest Dermatol; 2006 Jun; 126(6):1331-7. PubMed ID: 16575390
[TBL] [Abstract][Full Text] [Related]
12. A comparison of IgA positive and IgA negative dapsone responsive dermatoses.
Fry L; Walkden V; Wojnarowska F; Haffenden G; McMinn RM
Br J Dermatol; 1980 Apr; 102(4):371-82. PubMed ID: 7387881
[TBL] [Abstract][Full Text] [Related]
13. Childhood dermatitis herpetiformis. Review of the new aspects and report of a case.
Safai B; Rappaport I; Matsuoka L; Sogn D; Haines K; Lewin M
J Am Acad Dermatol; 1981 Apr; 4(4):435-41. PubMed ID: 7014663
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cells, IgA, C3, fibrin and fibronectin in skin lesions in dermatitis herpetiformis.
Reitamo S; Reunala T; Konttinen YT; Saksela O; Salo OP
Br J Dermatol; 1981 Aug; 105(2):167-77. PubMed ID: 7025880
[TBL] [Abstract][Full Text] [Related]
15. Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis.
Görög A; Németh K; Szabó L; Mayer B; Silló P; Kolev K; Kárpáti S
J Dermatol Sci; 2016 Oct; 84(1):17-23. PubMed ID: 27440075
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity-driven enzymatic remodeling of the dermal-epidermal junction in bullous pemphigoid and dermatitis herpetiformis.
Gornowicz-Porowska J; Bowszyc-Dmochowska M; Dmochowski M
Autoimmunity; 2012 Feb; 45(1):71-80. PubMed ID: 21916544
[TBL] [Abstract][Full Text] [Related]
17. Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.
Hall RP; Lawley TJ
J Immunol; 1985 Sep; 135(3):1760-5. PubMed ID: 4020133
[TBL] [Abstract][Full Text] [Related]
18. IgA in dermatitis-herpetiformis skin is dimeric.
Unsworth DJ; Payne AW; Leonard JN; Fry L; Holborow EJ
Lancet; 1982 Feb; 1(8270):478-9. PubMed ID: 6121142
[TBL] [Abstract][Full Text] [Related]
19. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Cynkier A; Sysa-Jedrzejowska A; Waszczykowska E
Mediators Inflamm; 2013; 2013():967987. PubMed ID: 23970818
[TBL] [Abstract][Full Text] [Related]
20. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.
Zebrowska A; Narbutt J; Sysa-Jedrzejowska A; Kobos J; Waszczykowska E
Mediators Inflamm; 2005 Dec; 2005(6):373-9. PubMed ID: 16489258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
